AIGH Capital Management »

Aziyo Biologics shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 1.7M 2.16
2023-09-30 $2.3M 1.8M 1.31

More positions owned by AIGH Capital Management

Aspen Aerogels (ASPN)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Transphorm (TGAN)
Ouster Com New (OUST)
Myomo Com New (MYO)
Electrovaya Com New (ELVA)
Alimera Sciences Com New (ALIM)
Tela Bio (TELA)
Biodesix (BDSX)
Coya Therapeutics Common Stock (COYA)
Brainsway Sponsored Ads (BWAY)
Spruce Biosciences (SPRB)
LivePerson (LPSN)
Theratechnologies Com New (THTX)

View all positions for AIGH Capital Management

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Perkins Capital Management
Worth Venture Partners
Vanguard Group
Indie Asset Partners
Millennium Management
Verdence Capital Advisors
Virtu Financial
Us Bancorp
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Aziyo Biologics